Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Insel Gruppe AG, University Hospital Bern
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
Able to undergo general anesthesia (ASA ≤ 4)
Performance status ECOG \<=2 (Eastern Cooperative Oncology Group)
Life expectancy of at least 6 months
Resectable, borderline resectable, or locally advanced pancreatic cancer
Patients who have locally advanced disease have to show no tumor progression after 3 month of neo-adjuvant chemotherapy+/-XRT before undergoing in situ IRE
You may not be if
Cardiac AV conduction abnormalities, ventricular fibrillation
History of epilepsy
Recent history of myocardial infarction (2 months)
Evidence of distant metastasis (e.g. liver, lung, peritoneum)
Informed consent cannot be given by the patient
Known hypersensitivity to the IRE electrodes (stainless steel 304L)
Women of childbearing potential who are pregnant, breast feeding, or not taking an adequate method of contraception at the time of procedure
Clareo Health | Immune Response After Pancreatic Cancer Treatment
